These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21704075)

  • 1. ALS: focus on purinergic signalling.
    Volonté C; Apolloni S; Carrì MT; D'Ambrosi N
    Pharmacol Ther; 2011 Oct; 132(1):111-22. PubMed ID: 21704075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purinergic signalling at the plasma membrane: a multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis.
    Amadio S; Apolloni S; D'Ambrosi N; Volonté C
    J Neurochem; 2011 Mar; 116(5):796-805. PubMed ID: 21214557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purinergic contribution to amyotrophic lateral sclerosis.
    Volonté C; Apolloni S; Parisi C; Amadio S
    Neuropharmacology; 2016 May; 104():180-93. PubMed ID: 26514402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events.
    Apolloni S; Montilli C; Finocchi P; Amadio S
    FEBS J; 2009 Jan; 276(2):354-64. PubMed ID: 19076216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purinergic implication in amyotrophic lateral sclerosis-from pathological mechanisms to therapeutic perspectives.
    Cieślak M; Roszek K; Wujak M
    Purinergic Signal; 2019 Mar; 15(1):1-15. PubMed ID: 30430356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters.
    Volonté C; D'Ambrosi N
    FEBS J; 2009 Jan; 276(2):318-29. PubMed ID: 19076212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purinergic signalling: from normal behaviour to pathological brain function.
    Burnstock G; Krügel U; Abbracchio MP; Illes P
    Prog Neurobiol; 2011 Oct; 95(2):229-74. PubMed ID: 21907261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purinergic signalling--an overview.
    Burnstock G
    Novartis Found Symp; 2006; 276():26-48; discussion 48-57, 275-81. PubMed ID: 16805422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
    Burnstock G
    Neuropharmacology; 2016 May; 104():4-17. PubMed ID: 26056033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroinflammation, COX-2, and ALS--a dual role?
    Consilvio C; Vincent AM; Feldman EL
    Exp Neurol; 2004 May; 187(1):1-10. PubMed ID: 15081582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axon guidance proteins: novel therapeutic targets for ALS?
    Schmidt ER; Pasterkamp RJ; van den Berg LH
    Prog Neurobiol; 2009 Aug; 88(4):286-301. PubMed ID: 19523502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of purinergic receptors in CNS function and neuroprotection.
    Tozaki-Saitoh H; Tsuda M; Inoue K
    Adv Pharmacol; 2011; 61():495-528. PubMed ID: 21586368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis.
    Lederer CW; Torrisi A; Pantelidou M; Santama N; Cavallaro S
    BMC Genomics; 2007 Jan; 8():26. PubMed ID: 17244347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel insights into how purines regulate pituitary cell function.
    Rees DA; Scanlon MF; Ham J
    Clin Sci (Lond); 2003 May; 104(5):467-81. PubMed ID: 12578557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in stem cell research for Amyotrophic Lateral Sclerosis.
    Papadeas ST; Maragakis NJ
    Curr Opin Biotechnol; 2009 Oct; 20(5):545-51. PubMed ID: 19819686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purinergic signaling involved in Müller cell function in the mammalian retina.
    Wurm A; Pannicke T; Iandiev I; Francke M; Hollborn M; Wiedemann P; Reichenbach A; Osborne NN; Bringmann A
    Prog Retin Eye Res; 2011 Sep; 30(5):324-42. PubMed ID: 21689780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonergic mechanisms in amyotrophic lateral sclerosis.
    Sandyk R
    Int J Neurosci; 2006 Jul; 116(7):775-826. PubMed ID: 16861147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional microglia neurotransmitters in amyotrophic lateral sclerosis.
    Volonté C; Amadio S; Fabbrizio P; Apolloni S
    Semin Cell Dev Biol; 2019 Oct; 94():121-128. PubMed ID: 31009755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroglial interactions mediated by purinergic signalling in the pathophysiology of CNS disorders.
    Matute C; Cavaliere F
    Semin Cell Dev Biol; 2011 Apr; 22(2):252-9. PubMed ID: 21320622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rethinking purinergic concepts and updating the emerging role of P2X7 and P2X4 in amyotrophic lateral sclerosis.
    Volonté C; Amadio S
    Neuropharmacology; 2022 Dec; 221():109278. PubMed ID: 36202258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.